Introduction {#Sec1}
============

Vitamin D deficiency is a risk factor for osteomalacia, osteoporosis and fractures \[[@CR1]\]. Multiple studies have demonstrated that vitamin D deficiency is also associated with an increased risk to develop other diseases, such as cancer \[[@CR1]\], diabetes \[[@CR2], [@CR3]\], sarcopenia \[[@CR4]\], cardiovascular \[[@CR5]\] and autoimmune disease \[[@CR6]\]. The increased awareness of the high prevalence of vitamin D deficiency has triggered an exponential increase in 25(OH)D testing.

The appropriate interpretation of serum 25(OH)D results is a matter of ongoing debate. Consequently, the recommended 25(OH)D cut-offs vary between different scientific bodies \[[@CR7]--[@CR10]\]. Age or gender specific cut-offs are not suggested by any guideline although several studies suggest that physiologic 25(OH)D requirements may vary with age, gender and ethnicity \[[@CR11]--[@CR15]\]. Interpretation of 25(OH)D results is further complicated by a variable accuracy of 25(OH)D assays and a strong seasonal variability of up to 20% \[[@CR16]--[@CR19]\]. Automated immunoassays represent the most widely used method in daily practice. However, the analytical performance of these assays varies substantially \[[@CR16]--[@CR19]\]. In particular, they vary in their efficiency to separate 25(OH)D from its carrier proteins and are often subject to interferences, such as high concentrations of 25(OH)D~2~ or heterophile antibodies. LC--MS/MS is the most accurate method for the measurement of 25(OH)D, but is mainly used in research laboratories.

Previous studies have shown a high prevalence of vitamin D deficiency in virtually all developed countries around the globe \[[@CR20]\]. However, many of these studies have used immunoassays for the measurement of 25(OH)D \[[@CR20]\]. Considering the analytical performance of 25(OH)D immunoassays, the trueness of results from previous epidemiologic studies is questionable.

Meanwhile, a reference method and a standard reference material (NIST SRM 972a) for the measurement of 25(OH)D have been developed \[[@CR21], [@CR22]\]. In addition, the Vitamin D Standardization Program (VDSP) has been launched with the goal to improve accuracy and comparability of analytical methods. However, until today, this initiative has only partially resolved the analytical issues of automated 25(OH)D immunoassays. Recently, Cashman et al. performed a reanalysis of previously measured samples with a standardized LC--MS/MS method \[[@CR20]\]. The results show substantial over- or underestimation of immunoassays. For example, in a German adult survey, the pre-standardization prevalence of 25(OH)D serum levels \< 30 nmol/L was 25.9% and decreased to 15.2% after standardization. In view of the analytical issues of immunoassays and the very low number of studies that have used higher order methods for the quantitation of 25(OH)D, the vitamin D status of most populations is not well described. Moreover, it remains unclear if the cut-off values proposed by various scientific bodies around the globe are applicable when a NIST 972a aligned LC--MS/MS method is used to measure 25(OH)D.

The present study aimed to describe the 25(OH)D status in South Tyrol, a mountainous region in the Southern European Alps using a rigorously controlled, NIST 972a aligned LC--MS/MS. In particular, we studied the distribution of serum 25(OH)D concentrations in males and females of different age groups, the prevalence of measurable amounts of 25(OH)D~2~ and seasonal variability.

Materials and methods {#Sec2}
=====================

Study design {#Sec3}
------------

We analyzed retrospectively all serum 25(OH)D results from outpatients that were generated between January 1, 2015 and December 31, 2016 at the Central Laboratory of Clinical Pathology at the Bolzano Hospital (Italy). Out of 74,235 samples 3801 cases were identified where PTH was requested at the same occasion. Results were used to study the distribution of serum 25(OH)D concentrations in males and females of different age groups, the prevalence of measurable amounts of 25(OH)D~2~ and seasonal variability.

All measurements were performed under routine circumstances. Samples were collected in serum tubes with clot activator. As per routine procedure, samples were centrifuged upon arrival in the lab and stored at 4 °C until measurement. 25(OH)D~3~ and 25(OH)D~2~ were quantitated separately. Results from subjects \< 18 years were excluded from the analysis. The study was approved by the local Ethics Committee.

Biochemical analyses {#Sec4}
--------------------

25(OH)D analyses by LC--MS/MS were performed as part of our routine clinical work with a commercial kit from Recipe (Munich, Germany) that is traceable to the NIST 972a standard reference material. The method is continuously controlled by daily internal and monthly external quality controls provided by the Royal Australian College of Pathologists Australasia Quality Assurance Program (RCPAQAP). Samples were measured on a Shimadzu 8040 LC--MS/MS instrument coupled to a UHPLC system (Nexera, Shimadzu). Sample preparation consisted in protein precipitation with zinc sulfate, the addition of internal standard (d6 25\[OH\]D~3~) eluted in methanol and subsequent online solid phase extraction (Recipe, code MS7030). The method was calibrated with ClinCal Serum Calibrators from RECIPE (Munich, Germany) and allow an equimolar detection of the two major 25(OH)D species, 25(OH)D~3~ and 25(OH)D~2~. According to manufacturer's declaration for 25(OH)D~3~, the assay is linear between 7.5 and 375 nmol/L, limit of detection(LoD) is 1.7 nmol/L and limit of quantification (LoQ) is 7.5 nmol/L. For 25(OH)D~2~, the assay is linear between 3.5 and 605 nmol/L, LoD is 1.0 and LoQ is 3.5 nmol/L. Imprecision is \< 8.8% and \< 8.7 for 25(OH)D~3~ and 25(OH)D~2~, respectively. In our laboratory, the long-term total imprecision was \< 7.3% at high and low levels. For statistical purposes, samples below the LoQ have been assigned a value of 3.75 nmol/L, which is half way between 0 and 7.5 nmol/L.

PTH was measured in lithium-heparin plasma using the PTH STAT assay from Roche Diagnostics (Mannheim, Germany) on a Cobas 8000 auto-analyzer. Total imprecision was 3.8 and 2.6% at concentrations of 13.6 and 361.3 pg/mL, respectively. The reference range provided in the manufacturers package insert is 15--65 pg/mL.

Statistical analysis {#Sec5}
--------------------

We calculated the following descriptive statistics: mean, median 2.5th, 5th 95th 97.5th percentile for total 25(OH)D, 25(OH)D~3~ and 25(OH)D~2~. Subgroups were formed on the base of gender, age, season and serum PTH. Differences between groups were explored using the Mann--Whitney (2 groups) or the Kruskal--Wallis (\> 2groups) test. A *p* value of \< 0.01 was considered significant. For post hoc analysis, a Wilcoxon test was used.

Seasonal variation was explored using the reference limit estimator (version 17.10.2015) developed by the German Society of Clinical Chemistry and Laboratory Medicine (DGKL), based on R version 3.1.0. In addition, 25(OH)D results were plotted against the date of analysis. A GAM (generalized additive model) model was used to smoothen the median over time and to calculate 95% CI for it. Using median values per month, a weighted spline-based smoothing function is applied.

Statistical analyses were performed with Microsoft Excel 2010 (Microsoft, Redmond, WA,USA) and Medcalc v17.4.4 software (Belgium).

Results {#Sec6}
=======

General characteristics of the cohort {#Sec7}
-------------------------------------

From all 74,235 serum 25(OH)D results, 18,811 (25.3%) were from males and 55,424 (74.7%) from females. The mean age of all subjects was 59.3 years (range 18--104 years). Serum 25(OH)D was predominantly tested in individuals between 41 and 80 years of age (75.4%). Subjects between 19 and 40 years accounted for only 14.6% of all requests. During summer/autumn, the number of requests was lower than in the winter/spring period: 35.316 requests (47.6%) vs. 38.919 requests (52.4%).

Global serum 25(OH)D status in the South Tyrolean population {#Sec8}
------------------------------------------------------------

The average 25(OH)D concentration in the entire cohort was 68.6 nmol/L (range 7.5--1880 nmol/L). The 2.5th and 97.5th percentile spanned a rather wide range from 12 to 159 nmol/L (Table [1](#Tab1){ref-type="table"}). In 0.5% of all samples, 25(OH)D was below 7.5 nmol/L, the LoQ of our method. Subjects with non-quantifiable 25(OH)D had a mean age of 68 years and were predominantly females. The prevalence of non-quantifiable 25(OH)D concentrations increased with age: 19--40 years: 9.5%, 41--60: 23.6%, 61--80: 32.5% and \> 80: 34.4%, respectively. Table [2](#Tab2){ref-type="table"} shows vitamin D distribution according to different 25(OH)D cut-off levels.

Table 125(OH)D concentration in 74,235 serum samples from South Tyrol---descriptive statisticsSexAll19--40 years41--60 years61--80 years\> 80 yearsM (*n* = 18,811)F (*n* = 55,424)M (*n* = 2684)F (*n* = 7900)M (*n* = 6437)F (*n* = 20,780)M (*n* = 7703)F (*n* = 21,076)M (*n* = 1987)F (*n* = 5668)25(OH)D, nmol/L---entire cohort Median6067\*5760\*6067\*5770\*5267\* Mean ± SD63.6 ± 39.970.2 ± 38.664 ± 44.666.0 ± 41.266.4 ± 42.570.1 ± 48.662.8 ± 3672.6 ± 36.657.5 ± 36.268 ± 41.5 2.5th--97.5th percentiles12--15012--15215--15215--15015--16217--15212--14215--15210--1377--159 5th--95th percentiles17--12517--13220--12720--12720--13522--13017--12220--13212--12010--137SexM (*n* = 548)F (*n* = 1684)M (*n* = 64)F (*n* = 133)M (*n* = 216)F (*n* = 654)M (*n* = 206)F (*n* = 688)M (*n* = 62)F (*n* = 209)25(OH)D, nmol/L---subjects with normal PTH Median7082\*63.575\*6775\*7786\*72.590\* Mean ± SD77.1 ± 43.385.9 ± 41.2269.6 ± 34.580.1 ± 41.4978.7 ± 48.880.6 ± 42.378.3 ± 40.189.47 ± 39.275.1 ± 37.694.3 ± 41.56 2.5th--97.5th percentile19--18522--18722--14722--19418--19922--18220--15223--17917--15316--205 5th--95th percentile22--15227--15722--13228--17924--18427--15223--13527--15520--14432--159\**p* \< 0.001 vs. males

Table 2Vitamin D distribution according to different 25(OH)D cut-off levels20 nmol/L30 nmol/L40 nmol/L50 nmol/L60 nmol/L75 nmol/L100 nmol/L125 nmol/L% below% above% below% above% below% above% below% above% below% above% below% above% below% above% below% above25(OH)D cut-off levelEntire cohort6.893.214.585.523.476.633.366.7455563.136.9851594.15.9M2.023.34.520.87.41810.31513.411.917.77.622324.11.3F4.869.91064.71658.62351.731.643.145.429.36312704.6

Prevalence of measurable serum 25(OH)D~2~ in the South Tyrolean population {#Sec9}
--------------------------------------------------------------------------

In 620 samples, 25(OH)D~2~ was detected in quantifiable concentrations. This accounts for 0.84% of the entire cohort. In subjects between 61 and 80 years, 25(OH)D~2~ was found most frequently. The average concentration in males and females was 13.5 and 17.0 nmol/L, respectively, and did not change with age (differences between age groups were not significant, supplementary table 1).

Differences in serum 25(OH)D status based on age and gender {#Sec10}
-----------------------------------------------------------

In males, the 25(OH)D concentration was significantly lower than in females (median 60 vs. 67 nmol/L, *p* \< 0.001). Although there was a median difference of 7 nmol/L between males and females, the 2.5th and 97.5th percentiles were rather similar (Table [1](#Tab1){ref-type="table"}). Figure [1](#Fig1){ref-type="fig"} shows the frequency distribution of total 25(OH)D results in males and females. The classification of 25(OH)D results according to the functional categories suggested by the Endocrine Society and the proportion of 25(OH)D categories by age group is shown in Fig. [2](#Fig2){ref-type="fig"}.

Fig. 1Frequency distribution of serum 25(OH)D concentrations in 18,811 women and 55,424 men from South Tyrol

Fig. 2Distribution of serum 25(OH)D concentrations in males and females of different age groups according to the categories recommended by the guidelines of the Endocrine Society Guideline

The mean total 25(OH)D concentration was lowest in males older than 80 years (Table [1](#Tab1){ref-type="table"}). Amongst women, the average 25(OH)D concentration increased with age. Although men also showed significant differences between age groups no clear trend could be observed. An adequate total 25(OH)D concentration (\> 76 nmol/L) was most frequently found in individuals aged 61--80 years (43.5% of all women and 30.6% of all men). Severe 25(OH)D deficiency (\< 25 nmol/L) was most common in subjects older than 80 years (19.7% of all men and 17% of all women in this age group).

Total 25(OH)D status in subjects with normal PTH {#Sec11}
------------------------------------------------

Out of 74,235 samples, we identified 3801 cases where PTH was requested at the same occasion. The origin of these requests was widespread and not attributable to a specific doctor or discipline. From these cases, 2,313 showed a normal PTH and thus were included in the analysis. In subjects with normal PTH, the mean serum 25(OH)D concentration was 11 nmol/L higher than in the entire cohort (80 vs. 68.6 nmol/L). The difference was more pronounced in women. The 2.5th and 5th percentiles of total 25(OH)D were comparable to the entire cohort, whereas the 95th and 97.5th percentiles differed by as much as 27 nmol/L (Table [1](#Tab1){ref-type="table"}).

Seasonal variation of total 25(OH)D {#Sec12}
-----------------------------------

Plotting the median 25(OH)D concentration against the date of blood collection showed a substantial seasonal variation of approximately 20--30% in both sexes with peaks of 25(OH)D in summer and autumn, and nadir between winter and spring (Fig. [3](#Fig3){ref-type="fig"}). The season-specific classification of 25(OH)D results according to the functional categories suggested by the Endocrine Society in males and females is presented in Fig. [4](#Fig4){ref-type="fig"} (7). In winter and spring 68.4% of the samples from females and 79.5% of the samples from males showed insufficient 25(OH)D concentrations (\< 75 nmol/L). During summer and autumn, the prevalence of insufficient 25(OH)D levels decreased to 52 and 59% for women and men, respectively.

Fig. 3Circannual variation of the median (dashed line) and its 95% confidence interval (dotted line) of serum 25(OH)D in males and females \> 18 years of age. A GAM model was used to smoothen the median and to calculate 95% CIs

Fig. 4Seasonal distribution of serum 25(OH)D concentrations in males and females according to the categories recommended by the guidelines of the Endocrine Society Guideline

The degree of seasonal variation differed with age. In subjects aged 19--40 years, the maximum seasonal change of serum 25(OH)D was 22.2 nmol/L, whereas in subjects \> 80 levels were rather constant (Fig. [5](#Fig5){ref-type="fig"}b). As expected, seasonal variation was observed for total 25(OH)D concentration, but not for 25(OH)D~2~ (Fig. [5](#Fig5){ref-type="fig"}a).

Fig. 5**a** Seasonal variation of mean total serum 25(OH)D and 25(OH)D~2~. **b** Seasonal variation of mean total serum 25(OH)D in different age group

Discussion {#Sec13}
==========

In South Tyrol, 25(OH)D is measured most frequently in women aged 61--80 years. The average concentration is 68.6 nmol/L with females having higher levels than males. The prevalence of vitamin D deficiency depends on season and gender, but is highest amongst subjects \> 80 years of age during winter and spring. 25(OH)D~2~ is measurable in 0.84% of all samples with an average concentration of 17 nmol/L.

The high number of requests in females is supposedly due to an increased awareness of the health issues related to vitamin D deficiency and a more frequent use of supplements. A similar requesting pattern has been reported in the UK \[[@CR23]\]. The average 25(OH)D concentration in South Tyrol is close to the sufficiency level and substantially higher than in other European cohorts \[[@CR24]--[@CR27]\]. These differences can be explained by the composition of the study cohorts, the amount of sun exposure, the season of blood collection and the analytical methods used. For example, in 8151 adult Germans, a mean serum 25(OH)D concentration of 45.6 nmol/L was found \[[@CR28]\]. This cohort was substantially younger than ours and lived at a latitude between 50° and 51° with approximately 1500 h of sunshine per year. In contrast, South Tyrol is located in the Southern Alps at a latitude of 46° and 47° and has approximately 2000 h of sunshine per year \[[@CR29]\]. Furthermore, South Tyrol is a mountainous region with many people living at an altitude between 1000 and 1500 m above sea level where UVB radiation is more intense due to a lower absorption in the atmosphere \[[@CR30]\]. In most previous studies, serum 25(OH)D was measured by immunoassays, which may differ systematically in their analytical performance from the NIST 972a aligned LC--MS/MS method used here.

On average South Tyrolean women show a 7 nmol/L higher 25(OH)D concentration than males. Schleicher et al. also observed 4 nmol/L higher 25(OH)D concentrations in white American women than in men \[[@CR31]\]. In contrast, other studies showed higher levels in males \[[@CR9], [@CR21]\] or no gender difference \[[@CR28], [@CR32]\]. These discrepancies might be caused by differences in life style, such as time spent outdoor, clothing and the use of supplements. It can be speculated that differences between males and females are population-specific and there may not be a systemic difference.

25(OH)D~2~ represents a major interference in immunoassays \[[@CR17], [@CR18]\]. Our results demonstrate a very low prevalence of quantifiable amounts of 25(OH)D~2~, which is much lower than in France, China and the USA, where vitamin D~2~-containing supplements are frequently used \[[@CR33]\]. As in most European countries, vitamin D supplements in Italy contain vitamin D~3~ this difference is not unexpected \[[@CR33]\]. Cashman et al. reported age and vitamin D supplementation as positive predictors of 25(OH)D~2~ \[[@CR20]\]. Considering that many immunoassays do not detect 25(OH)D~2~ and 25(OH)D~3~ in equimolar fashion laboratories should account for the local prevalence of quantifiable concentrations of 25(OH)D~2~ when choosing their method.

The average PTH concentration decreased continuously across classes of rising 25(OH)D concentrations from 122 pg/mL (25(OH)D: \< 25 nmol/L) to 49 pg/mL (25(OH)D: \> 250 nmol/L). Interestingly, none of the patients with a serum 25(OH)D concentration \> 250 nmol/L showed a suppressed PTH. In subjects with normal PTH, average 25(OH)D was 11 nmol/L higher than in the entire cohort, which alludes to a suboptimal supply with vitamin D in a relevant fraction of our cohort. In 507 subjects, serum calcium measurements were also available. Serum calcium was comparable in subjects with 25(OH)D concentrations \< 25 nmol/L (average 2.35 \[1.75--2.84\] mmol/L) and \> 250 nmol/L (2.38 \[1.56--2.89\] mmol/L). This suggests that the majority of subjects is able to maintain calcium/phosphate homeostasis across a wide range of 25(OH)D concentrations. Furthermore, hypercalcemia does not appear to be a common problem in the presence of excess 25(OH)D concentrations. The lack of clinical information in our cohort precludes an additional evaluation of bone and mineral metabolism. Nevertheless, our results are in agreement with previous studies showing a wide range of 25(OH)D concentrations in different populations with the 5th percentile at approximately ≤ 20 nmol/L. However, in other studies, the 5th percentile was substantially higher \[[@CR20]\]. However, all these studies have measured 25(OH)D by immunoassay. At low concentrations, these assays can deviate by more than 10 nmol/L from NIST 972a aligned LC--MS/MS methods \[[@CR17], [@CR20]\]. The limited accuracy of immunoassays is mainly due to different efficacies when separating 25(OH)D from VDBP and other carriers. 25(OH)D~2~ and heterophile antibodies are additional interfering factors that can cause inaccuracies \[[@CR17], [@CR18]\]. Besides analytical issues, strong regional variations of serum 25(OH)D have also been described \[[@CR26]\], which are in large parts driven by variable UV-B exposure, skin color, genetical differences (VDBP) and vitamin D supplementation.

The prevalence of vitamin D deficiency depends on the cut-off used and the season of blood collection. During summer/autumn, 23% of males and 18% of females have deficient 25(OH)D concentrations (\< 50 nmol/L). This increases by approximately 40--50% during winter and spring. Previous studies from Italy and other European countries reported a substantially higher prevalence of vitamin D deficiency ranging from 18.6 to 76.1% \[[@CR20]\]. In addition, the percentage of results in the adequate range \> 75 nmol/L is considerably higher in South Tyrol than in other regions. The high degree of sun exposure is probably a major driver of the rather good 25(OH)D status in South Tyrol. However, analytical issues may also have contributed to these differences.

Variable exposure to UV-B irradiation throughout the year strongly influences circulating 25(OH)D concentrations. In the present study, seasonal variation of serum 25(OH)D was 20 nmol/L in males and 15 nmol/L in females. With increasing age the seasonal variation of 25(OH)D decreases and disappears almost completely in individuals \> 80 years. This phenomenon can probably be explained by more sun exposure in younger individuals when compared to older subjects who live predominantly indoor and wear long clothes. In addition, aged skin is less effective in synthesizing vitamin D~3~ \[[@CR34]\]. However, seasonal variation of 25(OH)D differs substantially between studies \[[@CR35]--[@CR37]\]. 25(OH)D~2~, representing predominantly oral intake, varies little throughout the year.

Despite a large number of measurements, the present results are limited by an unknown number of repeat analyses in our cohort. In addition, the present cohort includes some vitamin D-supplemented subjects and individuals with renal impairment. However, the very large number of samples most likely compensates these shortcomings. Strict quality control standards and successful participation in an external quality assurance program where target values are aligned to the reference method lend particular strength to our results. Other epidemiologic studies from the USA, Norway and Netherlands that measured 25(OH)D by NIST 972a aligned LC--MS/MS methods found comparable 25(OH)D concentrations \[[@CR20], [@CR31]\].

In conclusion, average serum 25(OH)D in South Tyrol is higher than in other European cohorts. The majority of subjects is able to maintain normal calcium and PTH concentrations across a wide range of 25(OH)D concentrations. Seasonal variation is an important aspect in young and middle-aged adults, but becomes less relevant in elderly subjects. 25(OH)D~2~ is of minor practical importance in South Tyrol.
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